D.A. Davidson & CO. Has $366,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD)

D.A. Davidson & CO. lowered its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 6.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 299 shares of the medical instruments supplier’s stock after selling 21 shares during the period. D.A. Davidson & CO.’s holdings in Mettler-Toledo International were worth $366,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. State Street Corp raised its holdings in Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares during the period. Principal Financial Group Inc. raised its stake in shares of Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares in the last quarter. Barclays PLC lifted its position in Mettler-Toledo International by 8.3% in the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

MTD stock opened at $1,290.12 on Thursday. The stock has a market capitalization of $26.98 billion, a price-to-earnings ratio of 31.83, a P/E/G ratio of 3.30 and a beta of 1.13. The business has a fifty day moving average price of $1,289.38 and a 200 day moving average price of $1,331.49. Mettler-Toledo International Inc. has a fifty-two week low of $1,142.91 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on MTD. Robert W. Baird increased their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,368.00.

Insider Buying and Selling

In other news, insider Christian Magloth sold 790 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,530 shares of company stock valued at $2,024,192. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.